한글목차

척추 생물학적 제제의 동향과 예측

세계의 척추 생물학적 제제 시장은 2024-2030년의 CAGR이 4.5%로, 2030년까지 추정 33억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 척추 변형의 이환율 상승과 침습성 낮은 의료 기술에 대한 인식과 환자 지향의 증가입니다. 세계의 척추 생물학적 제제 시장의 미래는 병원과 외래 수술 센터 시장의 기회로 유망시되고 있습니다.

척추 생물학적 제제 시장 인사이트

Lucintel은 골이식은 질병 감염의 가능성을 낮게 하므로 예측 기간 중에도 최대 부문을 유지할 것으로 예측하고 있습니다.

이 시장내에서는 병원이 가장 높은 성장을 달성할 것으로 예상됩니다. 이것은 병원이 광범위한 헬스케어 자원을 갖추고 있으며, 전문 부문 및 학제적 팀을 포함하고 있으며, 척추 케어 서비스의 완전한 스펙트럼을 제공할 수 있기 때문입니다.

북미는 강고한 헬스케어 시스템, 주요 업계 리더의 존재, 이 지역에서 저침습 시술에 대한 인식과 요망의 증가에 의해 예측 기간 중 가장 높은 성장이 전망됩니다.

자주 묻는 질문

Q1.시장 규모는?

A1.세계의 척추 생물학적 제제 시장은 2030년까지 추정 33억 달러에 달할 것으로 예상되고 있습니다.

Q2.시장의 성장 예측은?

A2.세계의 척추 생물학적 제제 시장은 2024-2030년 CAGR 4.5%로 성장할 전망입니다.

Q3.시장의 성장에 영향을 미치는 주요 촉진요인은?

A3.이 시장의 주요 촉진요인은 척추 변형의 이환율 상승과 침습성 낮은 의료 기술에 대한 인식과 환자 지향의 증가입니다.

Q4.시장의 주요 부문은?

A4.척추 생물학적 제제 시장의 미래는 병원과 외래 수술 센터 시장에서의 기회로 유망합니다.

Q5.시장의 주요 기업은?

A5.척추 생물학적 제제의 주요 기업은 다음과 같습니다.

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Q6.향후 최대가 되는 시장 부문은?

A6.Lucintel은 골이식은 질병 감염의 가능성을 낮게 하므로 예측 기간 중 최대 부문을 유지할 것으로 예측하고 있습니다.

Q7.시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?

A7.북미는 강고한 헬스케어 시스템, 주요 업계 리더의 존재, 이 지역에서 저침습 시술에 대한 인식과 욕구의 증가에 의해 예측 기간 중 가장 높은 성장을 나타낼 것으로 예상됩니다.

Q8.리포트의 커스터마이즈는 가능?

A8.네, Lucintel은 추가 비용 없이 10%의 커스터마이즈를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 척추 생물학적 제제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 척추 생물제제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 척추 생물학적 제제 시장, 제품별
  • 골이식편
  • 골이식편대체품
  • 혈소판풍부혈장
  • 골수 흡인 요법
  • 기타
• 세계의 척추 생물학적 제제 시장, 재료별
  • 전경추 추간판 절제술과 고정술
  • 후부 요추체간 고정술
  • 경추간 요추체간 고정술
  • 전부 요추체간 고정술
  • 측방 요추체간 고정술
• 세계의 척추 생물제제 시장, 최종 용도 산업별
  • 병원
  • 외래 외과
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 척추 생물제제 시장
• 북미의 척추 생물제제 시장
• 유럽의 척추 생물제제 시장
• 아시아태평양의 척추 생물제제 시장
• 기타 지역의 척추 생물제제 시장

제5장 경쟁의 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 척추 생물학적 제제 시장의 성장 기회
  • 재료별 세계의 척추 생물학적 제제 시장의 성장 기회
  • 최종 용도 산업별 세계의 척추 생물제제 시장의 성장 기회
  • 지역별 세계의 척추 생물학적 제제 시장의 성장 기회
• 세계의 척추 생물학적 제제 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 척추 생물제제 시장의 능력 확대
  • 세계의 척추 생물학적 제제 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

영문목차

Spine Biologic Trends and Forecast

The future of the global spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets. The global spine biologic market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

A more than 150-page report is developed to help in your business decisions.

Spine Biologic by Segment

The study includes a forecast for the global spine biologic by product, material, end use industry, and region.

Spine Biologic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Bone Grafts
• Bone Graft Substitutes
• Platelet-Rich Plasma
• Bone Marrow Aspirate Therapy
• Others

Spine Biologic Market by Material [Shipment Analysis by Value from 2018 to 2030]:

• Anterior Cervical Discectomy & Fusion
• Posterior Lumbar Interbody Fusion
• Transforaminal Lumbar Interbody Fusion
• Anterior Lumbar Interbody Fusion
• Lateral Lumbar Interbody Fusion

Spine Biologic Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospital
• Ambulatory Surgical
• Others

Spine Biologic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Spine Biologic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies spine biologic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the spine biologic companies profiled in this report include-

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Spine Biologic Market Insights

Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Within this market, hospital is expected to witness the highest growth due to they are furnished with extensive healthcare resources, encompassing specialized divisions and interdisciplinary teams capable of delivering a complete spectrum of spinal care services.

North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Features of the Global Spine Biologic Market

Market Size Estimates: Spine biologic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Spine biologic market size by product, material, end use industry, and region in terms of value ($B).

Regional Analysis: Spine biologic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, material, end use industry, and regions for the spine biologic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the spine biologic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the spine biologic market size?

Answer: The global spine biologic market is expected to reach an estimated $3.3 billion by 2030.

Q2. What is the growth forecast for spine biologic market?

Answer: The global spine biologic market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the spine biologic market?

Answer: The major drivers for this market are rising incidence of spinal deformities and growing recognition and patient inclination toward less invasive medical techniques.

Q4. What are the major segments for spine biologic market?

Answer: The future of the spine biologic market looks promising with opportunities in the hospitals and ambulatory surgical centres markets.

Q5. Who are the key spine biologic market companies?

Answer: Some of the key spine biologic companies are as follows.

• Zimmer Biomet Holdings
• Johnson and Johnson
• Orthofix Medical
• Stryker
• Arthrex
• Medtronic
• K2M
• Exactech
• Wright Medical Technology
• Nuvasive

Q6. Which spine biologic market segment will be the largest in future?

Answer: Lucintel forecasts that bone graft will remain the largest segment over the forecast period due to it lowers the chances of disease transmission.

Q7. In spine biologic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to robust healthcare system, the presence of key industry leaders, and a growing awareness and desire for minimally invasive procedures in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the spine biologic market by product (bone grafts, bone graft substitutes, platelet-rich plasma, bone marrow aspirate therapy, and others), material (anterior cervical discectomy & fusion, posterior lumbar interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion, and lateral lumbar interbody fusion), end use industry (hospital, ambulatory surgical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Spine Biologic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Spine Biologic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Spine Biologic Market by Product
  • 3.3.1: Bone Grafts
  • 3.3.2: Bone Graft Substitutes
  • 3.3.3: Platelet-Rich Plasma
  • 3.3.4: Bone Marrow Aspirate Therapy
  • 3.3.5: Others
• 3.4: Global Spine Biologic Market by Material
  • 3.4.1: Anterior Cervical Discectomy & Fusion
  • 3.4.2: Posterior Lumbar Interbody Fusion
  • 3.4.3: Transforaminal Lumbar Interbody Fusion
  • 3.4.4: Anterior Lumbar Interbody Fusion
  • 3.4.5: Lateral Lumbar Interbody Fusion
• 3.5: Global Spine Biologic Market by End Use Industry
  • 3.5.1: Hospital
  • 3.5.2: Ambulatory Surgical
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Spine Biologic Market by Region
• 4.2: North American Spine Biologic Market
  • 4.2.2: North American Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.3: European Spine Biologic Market
  • 4.3.1: European Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.3.2: European Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.4: APAC Spine Biologic Market
  • 4.4.1: APAC Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.4.2: APAC Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others
• 4.5: ROW Spine Biologic Market
  • 4.5.1: ROW Spine Biologic Market by Product: Bone Grafts, Bone Graft Substitutes, Platelet-Rich Plasma, Bone Marrow Aspirate Therapy, and Others
  • 4.5.2: ROW Spine Biologic Market by End Use Industry: Hospital, Ambulatory Surgical, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Spine Biologic Market by Product
  • 6.1.2: Growth Opportunities for the Global Spine Biologic Market by Material
  • 6.1.3: Growth Opportunities for the Global Spine Biologic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Spine Biologic Market by Region
• 6.2: Emerging Trends in the Global Spine Biologic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Spine Biologic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Spine Biologic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zimmer Biomet Holdings
• 7.2: Johnson and Johnson
• 7.3: Orthofix Medical
• 7.4: Stryker
• 7.5: Arthrex
• 7.6: Medtronic
• 7.7: K2M
• 7.8: Exactech
• 7.9: Wright Medical Technology
• 7.10: Nuvasive